Covered recipient · General Payments record
JUSTINE A URYASZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2023
$3,183.26
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,067.34 | 10 |
| Food and Beverage | $439.89 | 7 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $1,204.36 | 10 |
| ATRICURE, INC. | $1,201.27 | 6 |
| KCI USA, Inc | $101.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $69.16 | 10/18/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019849811 | CMS |
| Abbott Laboratories | $278.08 | 10/18/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019849815 | CMS |
| Abbott Laboratories | $65.86 | 10/18/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019849819 | CMS |
| Abbott Laboratories | $31.80 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019849823 | CMS |
| Abbott Laboratories | $239.98 | 10/18/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019849827 | CMS |
| Abbott Laboratories | $65.86 | 10/18/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019849835 | CMS |
| Abbott Laboratories | $34.01 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019849979 | CMS |
| Abbott Laboratories | $9.07 | 10/18/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019850875 | CMS |
| Abbott Laboratories | $216.06 | 10/23/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019849865 | CMS |
| Abbott Laboratories | $194.48 | 10/23/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019849873 | CMS |
| ATRICURE, INC. | $713.33 | 04/04/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1012044903 | CMS |
| ATRICURE, INC. | $215.46 | 05/19/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1012174399 | CMS |
| ATRICURE, INC. | $42.37 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012174557 | CMS |
| ATRICURE, INC. | $50.85 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012180771 | CMS |
| ATRICURE, INC. | $25.99 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012180949 | CMS |
| ATRICURE, INC. | $153.27 | 12/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012200301 | CMS |
| KCI USA, Inc. | $101.60 | 07/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 986640379 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.